1.100
−8,33%
2026-08-28
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -259.2% | -1164.6% | 0 / 3 | -6.0% | -6.30 pp | -47.15 pp | -13.4% | 0.21 | — | 2,3 | −6,0% | −1,5 | −259,2% | — | 12.26 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.100 (close price on 2026-08-28)EPS (TTM): −1.317,4
Financial charts
1.Revenue & growth
VND bn2,27Q2/26
1.Revenue & growth
VND bn2,27Q2/26
2.Profit & growth
VND bn-1,45Q2/26
3.Profit mix (Penman)
VND bn-41,4Q2/26
4.Margins & cost structure
%-117%Q2/26
5.Returns & cash cycle
% · days-9.8%Q2/26
6.Earnings quality & cash
VND bn11,4Q2/26
7.Asset structure
VND bn415Q2/26
8.Funding & debt health
VND bn · times415Q2/26
9.Revenue backlog
VND bn2,71Q2/26
10.Valuation
times · %-0,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-46Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26